Caliway Biopharmaceuticals
6919.TWO
17.84 USD
-1.00
-5.31%
c
Overview
Last close
17.84 usd
Market cap
2.49B usd
52 week high
22.88 usd
52 week low
4.22 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2233.6877
Price/Book Value
24.9262
Enterprise Value
2.51B usd
EV/Revenue
2261.8011
EV/EBITDA
-102.5784
Key financials
Revenue TTM
1.11M usd
Gross Profit TTM
N/A usd
EBITDA TTM
-20.43M usd
Earnings per Share
-0.15 usd
Dividend
N/A usd
Total assets
N/A usd
Net debt
N/A usd
About
Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease. The company was founded in 2012 and is based in New Taipei City, Taiwan.
- Symbol6919.TWO
- ExchangeTWO
- IsinN/A
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CEOMs. Yufang Ling
- HeadquarterNew Taipei City
- Web sitehttps://www.caliway.com.tw
